Cargando…
Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa
Recent advances in viral vector engineering, as well as an increased understanding of the cellular and molecular mechanism of retinal diseases, have led to the development of novel gene therapy approaches. Furthermore, ease of accessibility and ocular immune privilege makes the retina an ideal targe...
Autores principales: | Li, Sujun, Datta, Shyamtanu, Brabbit, Emily, Love, Zoe, Woytowicz, Victoria, Flattery, Kyle, Capri, Jessica, Yao, Katie, Wu, Siqi, Imboden, Michael, Upadhyay, Arun, Arumugham, Rasappa, Thoreson, Wallace B., DeAngelis, Margaret M., Haider, Neena B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483267/ https://www.ncbi.nlm.nih.gov/pubmed/32123325 http://dx.doi.org/10.1038/s41434-020-0134-z |
Ejemplares similares
-
Modifier Genes as Therapeutics: The Nuclear Hormone Receptor Rev Erb Alpha (Nr1d1) Rescues Nr2e3 Associated Retinal Disease
por: Cruz, Nelly M., et al.
Publicado: (2014) -
Interspecies Correlations between Human and Mouse NR2E3-Associated Recessive Disease
por: Iannaccone, Alessandro, et al.
Publicado: (2021) -
Retinal detachment in retinitis pigmentosa
por: Chan, Weng Onn, et al.
Publicado: (2020) -
Retinitis pigmentosa
por: Hamel, Christian
Publicado: (2006) -
Metabolic rescue of cone photoreceptors in retinitis pigmentosa
por: Kaplan, Henry J., et al.
Publicado: (2021)